461 related articles for article (PubMed ID: 25800668)
1. High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan.
Sheikh SO; Jabeen K; Qaiser S; Ahsan ST; Khan E; Zafar A
Anaerobe; 2015 Jun; 33():132-6. PubMed ID: 25800668
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
[TBL] [Abstract][Full Text] [Related]
4. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007.
Jamal W; Shahin M; Rotimi VO
Anaerobe; 2010 Feb; 16(1):1-5. PubMed ID: 19406247
[TBL] [Abstract][Full Text] [Related]
5. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
Doğan M; Baysal B
Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility against metronidazole and carbapenem in clinical anaerobic isolates from Pakistan.
Shafquat Y; Jabeen K; Farooqi J; Mehmood K; Irfan S; Hasan R; Zafar A
Antimicrob Resist Infect Control; 2019; 8():99. PubMed ID: 31210928
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019.
Forbes JD; Kus JV; Patel SN
Anaerobe; 2021 Aug; 70():102386. PubMed ID: 34044100
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the routine antimicrobial susceptibility testing results of clinically significant anaerobic bacteria in a Slovenian tertiary-care hospital in 2015.
Jeverica S; Kolenc U; Mueller-Premru M; Papst L
Anaerobe; 2017 Oct; 47():64-69. PubMed ID: 28433670
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance among anaerobes isolated from clinical specimens in Kuwait hospitals: comparative analysis of 11-year data.
Jamal W; Al Hashem G; Rotimi VO
Anaerobe; 2015 Feb; 31():25-30. PubMed ID: 25193745
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility and clinical findings of significant anaerobic bacteria in southern Spain.
Cobo F; Rodríguez-Granger J; Pérez-Zapata I; Sampedro A; Aliaga L; Navarro-Marí JM
Anaerobe; 2019 Oct; 59():49-53. PubMed ID: 31103531
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
[TBL] [Abstract][Full Text] [Related]
12. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT
Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
Byun JH; Kim M; Lee Y; Lee K; Chong Y
Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
[TBL] [Abstract][Full Text] [Related]
14. Clinically significant anaerobic bacteria isolated from patients in a South African academic hospital: antimicrobial susceptibility testing.
Naidoo S; Perovic O; Richards GA; Duse AG
S Afr Med J; 2011 Sep; 101(10):732, 734. PubMed ID: 22272862
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility profiles of anaerobic pathogens in The Netherlands.
Veloo AC; van Winkelhoff AJ
Anaerobe; 2015 Feb; 31():19-24. PubMed ID: 25192966
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
Nord CE; Olsson-Liljequist B
Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
19. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
